Have we reached the limits for the treatment of diabetic nephropathy?

@article{Hajhosseiny2014HaveWR,
  title={Have we reached the limits for the treatment of diabetic nephropathy?},
  author={Reza Hajhosseiny and Kaivan Khavandi and Naheed Jivraj and Soudeh Mashayekhi and David J. A. Goldsmith and Rayaz A. Malik},
  journal={Expert opinion on investigational drugs},
  year={2014},
  volume={23 4},
  pages={511-22}
}
INTRODUCTION The prevalence of diabetic nephropathy is increasing as a consequence of the global epidemic of diabetes, and the complications of diabetic nephropathy are unsurprisingly legion. Blockade of the renin-angiotensin-aldosterone system (RAAS) has formed the mainstay of management, but despite this, most individuals will suffer premature… CONTINUE READING